Sale!

IGHM Gene Agammaglobulinemia Type 1 Autosomal Recessive NGS Genetic DNA Test

Original price was: $700.Current price is: $500.

-29%

The IGHM Gene Agammaglobulinemia Type 1 Autosomal Recessive NGS Genetic DNA Test is a cutting-edge diagnostic tool that identifies mutations in the IGHM gene responsible for causing Bruton’s agammaglobulinemia. This comprehensive test utilizes next-generation sequencing technology to detect autosomal recessive genetic variants that disrupt immunoglobulin M production, leading to severe antibody deficiency and increased susceptibility to infections. The test is crucial for individuals with recurrent bacterial infections, family history of immunodeficiency disorders, or unexplained immune system deficiencies. Early detection through this $500 USD test enables proactive management strategies, targeted treatment plans, and informed family planning decisions. Our advanced genetic analysis provides definitive diagnosis for this rare primary immunodeficiency condition.

Clinically Validated & Lab Certified

  • ISO-Accredited Laboratory, Ensuring Highest Standards
  • Trusted by Hospitals & Patients —Accredited Testing with Results
  • Direct Healthcare Provider Support + Comprehensive Reporting
Guaranteed Safe Checkout

IGHM Gene Agammaglobulinemia Type 1 Autosomal Recessive NGS Genetic DNA Test

Comprehensive Introduction to IGHM Gene Testing

The IGHM Gene Agammaglobulinemia Type 1 NGS Genetic DNA Test represents a breakthrough in molecular diagnostics for primary immunodeficiency disorders. This sophisticated genetic analysis specifically targets mutations in the IGHM gene, which encodes the mu heavy chain of immunoglobulin M (IgM) – a critical component of the human immune system. When this gene malfunctions due to autosomal recessive inheritance patterns, it leads to Bruton’s agammaglobulinemia, characterized by the near-complete absence of B cells and immunoglobulins.

Understanding the genetic basis of agammaglobulinemia is paramount for accurate diagnosis, appropriate treatment planning, and comprehensive family counseling. Our advanced NGS technology provides unparalleled accuracy in detecting even the most subtle genetic variations that conventional testing methods might miss.

What This Advanced Genetic Test Detects

The IGHM Gene Agammaglobulinemia Type 1 test employs cutting-edge Next-Generation Sequencing (NGS) technology to comprehensively analyze the entire IGHM gene sequence. This sophisticated approach identifies:

  • Point mutations affecting immunoglobulin mu heavy chain production
  • Small insertions and deletions disrupting gene function
  • Splice site mutations altering protein synthesis
  • Nonsense mutations leading to premature stop codons
  • Missense mutations affecting protein structure and function
  • Regulatory region variants impacting gene expression

This comprehensive analysis ensures detection of both known pathogenic variants and novel mutations that could contribute to the agammaglobulinemia phenotype.

Who Should Consider IGHM Genetic Testing

Clinical Indications and Symptoms

This genetic test is particularly recommended for individuals presenting with:

  • Recurrent bacterial infections beginning in infancy or early childhood
  • Family history of primary immunodeficiency disorders
  • Unexplained absence of B cells on flow cytometry
  • Severely reduced or undetectable immunoglobulin levels
  • Failure to thrive despite adequate nutrition
  • Chronic respiratory infections including pneumonia and bronchitis
  • Gastrointestinal infections and malabsorption issues
  • Autoimmune manifestations despite immunodeficiency

At-Risk Populations

  • Children with suspected X-linked or autosomal recessive agammaglobulinemia
  • Individuals with consanguineous parents
  • Patients with atypical immune deficiency presentations
  • Family members of diagnosed agammaglobulinemia patients
  • Couples planning pregnancy with family history of immunodeficiency

Significant Benefits of Early Genetic Diagnosis

Undergoing IGHM gene testing provides numerous critical advantages for patients and families:

  • Definitive Diagnosis: Confirms or rules out genetic agammaglobulinemia with high accuracy
  • Personalized Treatment: Enables targeted immunoglobulin replacement therapy
  • Infection Prevention: Facilitates proactive antibiotic prophylaxis strategies
  • Family Planning: Provides crucial information for genetic counseling and reproductive decisions
  • Improved Outcomes: Early intervention significantly reduces morbidity and mortality
  • Cost-Effective Care: Prevents unnecessary diagnostic procedures and inappropriate treatments
  • Psychological Relief: Reduces diagnostic uncertainty and provides clear management pathways

Understanding Your Genetic Test Results

Interpretation Guidelines

Our comprehensive genetic report provides detailed analysis with clear interpretation:

  • Positive Result: Identifies pathogenic mutations in both IGHM gene copies, confirming autosomal recessive agammaglobulinemia diagnosis
  • Carrier Status: Detection of a single mutated IGHM gene copy indicates carrier status without disease manifestation
  • Negative Result: No pathogenic variants detected, suggesting alternative diagnoses for immunodeficiency
  • Variant of Uncertain Significance: Identifies genetic changes requiring additional clinical correlation

Clinical Implications

Positive results necessitate immediate consultation with immunology specialists for implementation of immunoglobulin replacement therapy, infection monitoring protocols, and comprehensive management strategies. Carrier status information is invaluable for family planning and genetic counseling.

Test Information and Pricing

Test Component Details
Test Name IGHM Gene Agammaglobulinemia Type 1 Autosomal Recessive NGS Genetic DNA Test
Discount Price $500 USD
Regular Price $700 USD
Turnaround Time 3 to 4 Weeks
Sample Type Blood EDTA Tube
Testing Method Next-Generation Sequencing (NGS)
Specialty Hematology Genetics

Pre-Test Requirements and Preparation

To ensure optimal testing accuracy and comprehensive genetic assessment, we require:

  • Complete clinical history documenting immune deficiency symptoms and infection patterns
  • Genetic counseling session to construct detailed family pedigree
  • Documentation of previous immunological testing results
  • Informed consent for genetic testing and result disclosure
  • Insurance pre-authorization when applicable

Nationwide Accessibility and Convenience

We proudly serve patients across the United States with convenient testing locations in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, and numerous other cities. Our network of certified collection centers ensures accessible genetic testing services nationwide.

Take Control of Your Genetic Health Today

Don’t let uncertainty about immune deficiency disorders compromise your health or quality of life. Our IGHM Gene Agammaglobulinemia Type 1 NGS Genetic DNA Test provides definitive answers and clear direction for effective management. Early genetic diagnosis can transform treatment outcomes and prevent serious complications.

Call or WhatsApp us now at +1(267) 388-9828 to schedule your genetic counseling session and testing appointment. Our compassionate genetic specialists are ready to guide you through every step of the testing process and help you understand your results.

Take the first step toward definitive diagnosis and personalized treatment. Book your IGHM genetic test today and gain the clarity needed for optimal immune health management.